Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

The oncologist·2026
Same author

Assessing the influence of chlorantraniliprole on agricultural soils: Dissipation kinetics, degradation, microbial activity and functional biodiversity.

Environmental pollution (Barking, Essex : 1987)·2025
Same author

Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators.

The journal of prevention of Alzheimer's disease·2024
Same author

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

Radiation research·2023
Same author

RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome Assay.

Radiation research·2023
Same author

Seizure prophylaxis in meningiomas: a systematic review and meta-analysis.

Neurologia·2022

Related Experiment Video

Updated: Jun 1, 2026

Detection of Abnormal Prion Protein by Immunohistochemistry
06:38

Detection of Abnormal Prion Protein by Immunohistochemistry

Published on: May 5, 2023

Structural and functional neuroimaging in human prion diseases.

S Ortega-Cubero1, M R Luquín, I Domínguez

  • 1Departamento de Neurología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. sortegac@unav.es

Neurologia (Barcelona, Spain)
|May 31, 2011
PubMed
Summary

Prion diseases are fatal neurodegenerative conditions. This review details neuroimaging findings to aid in diagnosing these challenging disorders, focusing on complementary examinations for better pre-mortem identification.

More Related Videos

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Related Experiment Videos

Last Updated: Jun 1, 2026

Detection of Abnormal Prion Protein by Immunohistochemistry
06:38

Detection of Abnormal Prion Protein by Immunohistochemistry

Published on: May 5, 2023

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Prion diseases stem from misfolded prion protein (PrPc) accumulation, presenting as acquired, sporadic, or hereditary forms.
  • These neurodegenerative disorders share a fatal outcome despite varied clinical and pathological presentations.
  • While some prion diseases like kuru are rare, others like variant Creutzfeldt-Jakob disease (vCJD) remain a medical challenge.

Purpose of the Study:

  • To review neuroimaging findings across various prion diseases.
  • To assess the diagnostic utility of complementary examinations in prion disease diagnosis.
  • To correlate histopathological diagnoses with specific neuroimaging features.

Main Methods:

  • Review of neuroimaging findings in patients with confirmed prion disease diagnoses.
  • Analysis of complementary diagnostic tests including electroencephalogram (EEG) and 14-3-3 protein detection in cerebrospinal fluid (CSF).
  • Focus on magnetic resonance imaging (MRI) findings, particularly the pulvinar sign for vCJD.

Main Results:

  • Definitive pre-mortem diagnostic tests are lacking for most prion diseases, except for vCJD via tonsil biopsy.
  • Diagnostic criteria often rely on statistical probability, supplemented by EEG and CSF 14-3-3 protein analysis.
  • Specific MRI signs, like the pulvinar sign, are crucial for diagnosing certain prion diseases such as vCJD.

Conclusions:

  • Neuroimaging plays a vital role in the diagnostic process for prion diseases.
  • Complementary examinations, especially MRI, are essential tools for improving pre-mortem diagnosis.
  • Further research into diagnostic markers is needed to effectively manage these fatal neurodegenerative conditions.